Tag

Medicines

Affordable drugs How dare you, Novartis?

28 February 2020

Victory for public health Novartis drops the Kymriah patent that was opposed by Public Eye

16 December 2019

Affordable drugs Novartis cancer treatment for CHF 370,000?! Public Eye opposes Kymriah patent

3 July 2019

Report Post-Trial Access to Swiss Medicines

Clinical trials Roche and Novartis neglect their ethical responsibility in emerging countries

20 May 2019

Panel discussion No fair pricing without transparency

11 April 2019

News Stop TRIPS-plus measures in trade agreement with Indonesia

6 November 2018

Press Release 33,000 signatures: curb the exorbitant cost of medicines

13 September 2018

Report Protect patients, not patents

Press Release Compulsory licensing in Colombia: Aggressive lobbying by Novartis

12 April 2017